Johnson & Johnson (JNJ) Total Debt (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Total Debt came in at $60.7 billion in Q2 2026, down 2.5% year-over-year from $62.3 billion in Q2 2025, and down 16.18% quarter-over-quarter from $72.4 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Total Debt (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Total Debt across 18 years of filings, most recently posting $60.7 billion for Q2 2026.
- In Q2 2026, Total Debt fell 2.5% year-over-year to $60.7 billion; the TTM figure through Jun 2026 stood at $60.7 billion (down 2.5% YoY), while the FY2025 annual figure was $56.4 billion, up 27.19% from the prior year.
- Total Debt came in at $60.7 billion for Q2 2026 at Johnson & Johnson, down from $72.4 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $72.4 billion in Q1 2026 to a low of $33.8 billion in Q4 2023.
- Average Total Debt over 5 years is $49.9 billion, with a median of $51.3 billion recorded in 2024.
- Year-over-year, Total Debt soared 89.31% in 2023 and slumped 40.49% in 2024.
- Over 5 years, Total Debt stood at $36.5 billion in 2022, then dropped by 6.03% to $34.3 billion in 2023, then climbed by 29.53% to $44.4 billion in 2024, then rose by 27.19% to $56.4 billion in 2025, then climbed by 7.62% to $60.7 billion in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $60.7 billion in Q2 2026, $72.4 billion in Q1 2026, and $56.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 38.81 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 5.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 60.73 Bn |
| Mar 29, 2026 | 72.45 Bn |
| Dec 28, 2025 | 56.43 Bn |
| Sep 28, 2025 | 52.18 Bn |
| Jun 29, 2025 | 62.29 Bn |
| Mar 30, 2025 | 66.15 Bn |
| Dec 29, 2024 | 44.37 Bn |
| Sep 29, 2024 | 40.21 Bn |
| Jun 30, 2024 | 51.35 Bn |
| Mar 31, 2024 | 42.18 Bn |
| Dec 31, 2023 | 34.25 Bn |
| Oct 1, 2023 | 33.79 Bn |
| Jul 2, 2023 | 57.30 Bn |
| Apr 2, 2023 | 70.89 Bn |
| Jan 1, 2023 | 53.95 Bn |
| Oct 2, 2022 | 36.45 Bn |
| Jul 3, 2022 | 36.90 Bn |
| Apr 3, 2022 | 37.45 Bn |
| Jan 2, 2022 | 39.65 Bn |
| Oct 3, 2021 | 37.73 Bn |